Newsletter | April 29, 2024

Best of April: Top 5 Insights In Clinical Trial Technology

Clinical Tech Leader

TOP 5 INSIGHTS IN CLINICAL TRIAL TECHNOLOGY
APRIL EDITION

#1 - AI Technologies Drive Drug Development And Enhance Patient Experience In Neurology & Rare Diseases

Digital healthcare and AI technologies play a crucial role in exploring and treating a range of rare diseases as we welcome a new era of personalized care and potentially better patient outcomes.

#2 - Powering Your Research Potential: Exploring Medrio CDMS/EDC

In this segment from Clinical Leader's Solutions Expo: EDC Showcase, Medrio CEO Nicole Latimer and Principal Solutions Consultant Jack Cornwall take viewers through an exclusive inside look at their CDMS/EDC solution.

#3 - Why Jane Myles Believes DCTs Are “Completely Doable”

If you want to know about how perceptions regarding DCTs are changing, talk with Jane Myles, Program Director of the Decentralized Trials & Research Alliance (DTRA). She is acutely aware of all the challenges and opportunities surrounding anything with the term “decentralized trial.”

#4 - Empowering Medical Affairs: Strategies To Enhance And Expand Your Team’s Impact

Medical affairs are vital, bridging pharma, professionals, and patients. Explore insights for navigating industry shifts, leveraging technology, and empowering professionals in this dynamic landscape.

#5 - Ignoring Digital Biomarkers Will Be Your Undoing

Bari Kowal, SVP of development operations, portfolio management & biostatistics data management at Regeneron, reveals that the industry is just scratching the surface of digital biomarker benefits, highlighting the challenge of identifying reliable, repeatable measurements.